Surescripts CEO Steps Down | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

Surescripts CEO Steps Down

January 10, 2014
by Gabriel Perna
| Reprints
Harry Totonis Credit: Surescripts

Harry Totonis, the CEO and President of Surescripts, will step down from the company in March after five years on the job, he announced this week.

Totonis came to Surescripts, which operates a national clinical electronic prescribing (ePrescribing) network that connects payers, providers, and pharmacies, after a merger with RxHUB in 2008. He was appointed CEO in March of 2009. Under his leadership, the Surescripts network has grown to transmit more than 6 billion health data transactions annually, connecting more than 500,000 prescribers, 94 percent of community pharmacies, the nation's PBMs, EHR/EMR vendors and many hospitals.

"Harry is a visionary - responsible for the transformation of Surescripts into the nation's leading clinical network that is shaping how healthcare connects and communicates by expanding capabilities to enable interoperability between health systems, physicians and pharmacists,"  Steven Miller, M.D., Co-Chairman of Surescripts' Board of Directors, said in a statement. "We are extremely pleased with what Harry has accomplished and believe the company is well positioned for continued success."

The Board of Directors has begun an executive search for a successor.

Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More



KLAS Research: Small Hospitals’ Buying Decisions Impacting EMR Market Share

A new KLAS Research report tracks shifts in electronic medical record (EMR) vendor market share among acute care hospitals, and finds that smaller hospitals are seeking technology solutions that meet their needs and limited budgets, and these contracts are making a mark on the EMR market.

Survey: Majority of Providers Predict Success for New Generic Drug Company, Project Rx

Back in January, four health systems, in consultation with the VA, announced a collaboration to develop a new, not-for-profit generic drug company. A survey has found that 90 percent of providers say they would become customers of the new venture.

Personalized Medicine Awareness Low Among U.S. Adults, Survey Finds

Genetics and personalized medicine are not top of mind for the general public in the U.S., according to a recent survey from GenomeWeb and the Personalized Medicine Coalition.

Industry Organizations Praise Senate Passage of VA Mission Act

The U.S. Senate on Wednesday passed, by a vote of 92-5, a major Veterans Affairs (VA) reform bill that includes health IT-related provisions to improve health data exchange between VA healthcare providers and community care providers.

NIH Issues Funding Announcement for All of Us Genomic Research Program

The National Institutes of Health’s (NIH) “All of Us” Research Program has issued a funding announcement for genome centers to generate genotype and whole genome sequence data from participants’ biosamples.

MGMA: Physician Compensation Data Illustrates Nationwide PCP Shortage

Primary care physicians’ compensation rose by more than 10 percent over the past five years, representing an increase which is nearly double that of specialty physicians’ compensation over the same period, according to the Medical Group Management Association (MGMA).